Giulia Spagnol

15PUBLICATIONS
60CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Obstetrics and gynaecologyLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 17, 2026
Combinatorial delivery of low-dose radiotherapy and immunotherapy to patients with immune-excluded tumors enhances CD8+ T cell functionality.

|Mar 09, 2026
Validation of molecular classification on diagnostic biopsy in endometrial carcinoma: the first step for a tailored approach.

Giulia Spagnol, Matteo Marchetti, Tommaso Vezzaro

|Jun 13, 2025
Unraveling Homologous Recombination Deficiency in Ovarian Cancer: A Review of Currently Available Testing Platforms.

Nicola Marconato, Orazio De Tommasi, Dino Paladin

|Dec 17, 2024
The Role of Immunotherapy in MMR-Deficient Endometrial Carcinoma: State of the Art and Future Perspectives.

Matteo Marchetti, Jacopo Ferrari, Tommaso Vezzaro

|Nov 27, 2024
Δ-Peritoneal Cancer Index (Δ-PCI) to Predict Complete Cytoreduction and Histopathological Response to Neoadjuvant Chemotherapy in Ovarian Cancer.

Giulia Spagnol, Sofia Bigardi, Michela Zorzi

|Oct 16, 2024
Nerve-Sparing Laparoscopic Radical Hysterectomy (nsLRH) without Adjuvant Therapy in FIGO Stage IB3 Cervical Cancer Patients: Surgical Technique and Survival Outcomes.

Roberto Tozzi, Sofia Bigardi, Giulia Spagnol

Pageof 3

Frequent Collaborators

11 joint publications

Roberto Tozzi

8 joint publications

Matteo Marchetti

8 joint publications

Carlo Saccardi

5 joint publications

Sofia Bigardi